We are live on
!
Find out more
Group One Trading Portfolio holdings
AUM
$52.2B
1-Year Est. Return
104.56%
This Fund
S&P 500
This Quarter
Est. Return
+18.67%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,561.13%
AUM
$43.7B
AUM Growth
+$8.61B
(+25%)
Cap. Flow
+$8.81B
Cap. Flow
% of AUM
20.17%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
8,209
New
1,667
Increased
2,750
Reduced
2,399
Closed
1,045
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$47.9M |
| 2 |
GXO Logistics
GXO
|
+$41.8M |
| 3 |
Eli Lilly
LLY
|
+$34.9M |
| 4 |
First Solar
FSLR
|
+$31.5M |
| 5 |
Iris Energy
IREN
|
+$28.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$69.1M |
| 2 |
AST SpaceMobile
ASTS
|
+$49.8M |
| 3 |
NVIDIA
NVDA
|
+$44.4M |
| 4 |
CleanSpark
CLSK
|
+$43M |
| 5 |
Citigroup
C
|
+$37.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.43% |
| 2 | Healthcare | 1.12% |
| 3 | Financials | 0.87% |
| 4 | Consumer Discretionary | 0.61% |
| 5 | Industrials | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBBY
4801
PUT
Bed Bath & Beyond
BBBY
$481M
| $71K | ﹤0.01% |
15,840
-56,540
| -78% | -$360K |
|
4802
PUT
Fortress Biotech
FBIO
$104M
| $70.9K | ﹤0.01% |
35,000
+4,000
| +13% | +$7.25K |
|
4803
PUT
Zillow
ZG
$7.94B
| $70.8K | ﹤0.01% |
1,000
-14,500
| -94% | -$1,000K |
|
4804
CALL
Monte Rosa Therapeutics
GLUE
$1.4B
| $70.8K | ﹤0.01% |
+10,200
| New | +$76.5K |
|
4805
PUT
Old Dominion Freight Line
ODFL
$44.1B
| $70.6K | ﹤0.01% |
400
-1,400
| -78% | -$285K |
|
4806
CALL
VistaGen Therapeutics
VTGN
$9.89M
| $70.5K | ﹤0.01% |
23,900
+400
| +2% | +$1.13K |
|
4807
CALL
Quince Therapeutics
QNCX
$22.9M
| $70.5K | ﹤0.01% |
+189
| New | +$56.8K |
|
4808
Outdoor Holding Co
POWW
$249M
| $70.3K | ﹤0.01% |
63,904
-3,737
| -6% | -$4.45K |
|
4809
PUT
ARK Space & Defense Innovation ETF
ARKX
$793M
| $70.3K | ﹤0.01% |
+3,600
| New | +$64.9K |
|
4810
PUT
Shoals Technologies Group
SHLS
$1.47B
| $70.2K | ﹤0.01% |
12,700
-9,200
| -42% | -$46.7K |
|
|
SKX
4811
DELISTED
Skechers
SKX
| $70.2K | ﹤0.01% |
+1,044
| New | +$67.7K |
|
|
VXRT
4812
DELISTED
Vaxart
VXRT
| $70.1K | ﹤0.01% |
105,896
+39,094
| +59% | +$27.2K |
|
4813
PUT
Ternium
TX
$9.67B
| $69.8K | ﹤0.01% |
2,400
-700
| -23% | -$23.4K |
|
4814
CALL
Xylem
XYL
$27.3B
| $69.6K | ﹤0.01% |
+600
| New | +$75.9K |
|
4815
CALL
Upland Software
UPLD
$12.8M
| $69.4K | ﹤0.01% |
1,600
+1,500
| +1,500% | +$48.7K |
|
|
FRGE
4816
DELISTED
Forge Global Holdings
FRGE
| $69.4K | ﹤0.01% |
4,972
-1,018
| -17% | -$16.8K |
|
4817
Schwab US Dividend Equity ETF
SCHD
$103B
| $69.2K | ﹤0.01% |
+2,533
| New | +$72K |
|
4818
CALL
Daktronics
DAKT
$955M
| $69.1K | ﹤0.01% |
4,100
-12,100
| -75% | -$182K |
|
4819
CALL
Atossa Therapeutics
ATOS
$20.6M
| $69K | ﹤0.01% |
4,873
-394
| -7% | -$7.69K |
|
4820
CALL
Annovis Bio
ANVS
$74.4M
| $68.9K | ﹤0.01% |
13,700
-174,700
| -93% | -$1.26M |
|
4821
PUT
Arbutus Biopharma
ABUS
$857M
| $68.3K | ﹤0.01% |
20,900
+400
| +2% | +$1.47K |
|
4822
PUT
Getty Images
GETY
$156M
| $68.3K | ﹤0.01% |
31,600
-19,500
| -38% | -$63.6K |
|
4823
Fossil Group
FOSL
$293M
| $68.2K | ﹤0.01% |
40,840
-67,096
| -62% | -$98K |
|
|
LOMA
4824
PUT
Loma Negra
LOMA
$1.34B
| $68.1K | ﹤0.01% |
5,700
+800
| +16% | +$8.3K |
|
4825
PUT
Apogee Therapeutics
APGE
$10.1B
| $68K | ﹤0.01% |
+1,500
| New | +$76.5K |
|
Similar funds
SCP
Group One Trading's Q4 2024 Portfolio in Review
As of Q4 2024, Group One Trading held 8,209 positions worth $43.7B, up 25% from $35.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Group One Trading deployed $8.81B of net new capital in Q4 2024, opening 1,667 new positions and adding to 2,750 existing holdings. Its largest new stake was Eli Lilly: 42,101 shares worth $32.5M.
By sector, the portfolio is most concentrated in Technology at 1.4% of assets, down from 1.8% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Robinhood, an estimated $69.1M trimmed.
- Group One Trading's largest Q4 2024 buy was Eli Lilly: 42,101 shares worth $32.5M.
- Group One Trading added most to UnitedHealth in Q4 2024, an estimated $47.9M increase.
- Group One Trading's biggest Q4 2024 reduction was Robinhood, cutting an estimated $69.1M.
- Group One Trading fully exited CleanSpark in Q4 2024, selling an estimated $43M.
- Group One Trading's ten largest holdings make up 22% of its $43.7B portfolio in Q4 2024.
- Group One Trading opened 1,667 new positions and closed 1,045 in Q4 2024.
- Group One Trading's portfolio value rose 25% quarter-over-quarter to $43.7B.
Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.